1. Home
  2. EXLS vs BLLN Comparison

EXLS vs BLLN Comparison

Compare EXLS & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ExlService Holdings Inc.

EXLS

ExlService Holdings Inc.

HOLD

Current Price

$35.30

Market Cap

5.3B

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$117.32

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXLS
BLLN
Founded
1999
2016
Country
United States
United States
Employees
65000
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
4.4B
IPO Year
2004
2025

Fundamental Metrics

Financial Performance
Metric
EXLS
BLLN
Price
$35.30
$117.32
Analyst Decision
Strong Buy
Buy
Analyst Count
5
7
Target Price
$46.80
$126.71
AVG Volume (30 Days)
1.7M
495.8K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
27.27
103.40
EPS
0.43
0.48
Revenue
N/A
$305,112,000.00
Revenue This Year
$12.61
$46.29
Revenue Next Year
$10.55
$30.14
P/E Ratio
$82.00
$216.38
Revenue Growth
N/A
99.97
52 Week Low
$24.85
$61.96
52 Week High
$44.32
$150.44

Technical Indicators

Market Signals
Indicator
EXLS
BLLN
Relative Strength Index (RSI) 50.40 51.97
Support Level $34.33 $79.07
Resistance Level $36.55 $108.50
Average True Range (ATR) 0.85 4.98
MACD -0.31 1.52
Stochastic Oscillator 34.11 54.91

Price Performance

Historical Comparison
EXLS
BLLN

About EXLS ExlService Holdings Inc.

ExlService Holdings Inc. is a data analytics and digital operations company that provides data and AI-led solutions and technology-enabled services to clients across industries. The company has four reportable segments. The Insurance segment provides services such as claims management, underwriting support, and analytics solutions. The Healthcare and Life Sciences segment offers data-driven solutions and services to healthcare payers, providers, and life sciences organizations. The Banking, Capital Markets and Diversified Industries segment delivers solutions across financial services and other industries. The International Growth Markets segment focuses on providing data, AI, and digital operations services to clients outside North America.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: